CoChat
Sign Up
Cited by 98Cancer Immunotherapy and BiomarkersImmune cells in cancerImmunotherapy and Immune Responses

High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy

Open access
Gubin, Matthew M., Esaulova, Ekaterina, Ward, Jeffrey P., Malkova, Olga N., Runci, Daniele, Wong, Pamela, Noguchi, Takuro, Arthur, Cora D. +11 more·2018·Cell
DOI 10.1016/j.cell.2018.11.003
Open this paper in CoChat — free accountOpen PDF

Integrity signals

Registry

Crossref · 10.1016/j.cell.2018.11.003

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • These changes partially overlapped with those reported in a model of MCA-induced sarcoma treated with optimal anti-PD-1.

    “These changes partially overlapped with those reported in a model of MCA-induced sarcoma treated with optimal anti-PD-1 (Gubin et al., 2018).”

    From TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy (2020) · cites this paper as Gubin et al., 2018

Cited by

Sorted by citations

Authors
Gubin, M. M., Esaulova, E., Ward, J. P., Malkova, O. N., Runci, D., Wong, P., Noguchi, T., Arthur, C. D., Meng, W., Alspach, E., Medrano, R. F. V., Fronick, C., Fehlings, M., Newell, E. W., Fulton, R. S., Sheehan, K. C. F., Oh, S. T., Schreiber, R. D., & Artyomov, M. N.
Corresponding author
  • Schreiber, Robert D.
  • Artyomov, Maxim N.
ORCID
Venue
Cell
Publisher
Elsevier BV
Published
2018-11
Volume
175
Issue
5
Pages
1443
ISSN
0092-8674 (ISSN-L)
DOI
10.1016/j.cell.2018.11.003
OpenAlex
W3026809871
Cited by
98
References
0
Citations by year
2026: 6 · 2025: 10 · 2024: 11 · 2023: 16 · 2022: 15 · 2021: 16 · 2020: 14 · 2019: 8 · 2018: 2
FWCI
3.78
Type
journal article
Language
en
Open access
Licence
Locations
Cell (publishedVersion)
Funders
National Cancer Institute (R01CA190700, P30CA091842)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords
immune checkpoint inhibitors, tumor microenvironment, myeloid cells, lymphoid cells, intratumoral macrophages, macrophage polarization, CX3CR1, CD206, inducible nitric oxide synthase, tumor-infiltrating lymphocytes, antitumor immunity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review